SS-31
A mitochondria-targeted peptide studied for mitochondrial function, oxidative stress, cellular energy handling, and tissue protection in experimental models.
An informational reference library for peptides, metabolic compounds, signaling molecules, bioregulators, and research reagents. No products are sold here.
A searchable educational reference covering compounds, research areas, and current scientific context.
A mitochondria-targeted peptide studied for mitochondrial function, oxidative stress, cellular energy handling, and tissue protection in experimental models.
A modified fragment of human growth hormone investigated primarily in laboratory and early clinical research related to lipid metabolism and body-composition pathways.
A human antimicrobial peptide studied for innate immune signaling, microbial defense, inflammation, wound biology, and tissue repair.
An experimental peptide studied mainly in preclinical models for effects on blood vessels associated with adipose tissue. Human evidence is limited.
A research combination involving a GHRH analog and a ghrelin-receptor agonist, studied for growth-hormone secretory signaling. Combination evidence is limited.
A naturally occurring copper-binding peptide studied for extracellular-matrix signaling, skin biology, wound repair, hair biology, and tissue remodeling.
A long-acting growth-hormone-releasing hormone analog investigated for its effects on growth-hormone and IGF-1 signaling.
A shorter-acting GHRH analog used in research on pulsatile growth-hormone secretion and related endocrine signaling.
A major intracellular antioxidant studied for redox balance, detoxification pathways, oxidative stress, and cellular defense.
A synthetic growth-hormone secretagogue studied for ghrelin-receptor signaling, growth-hormone release, appetite signaling, and metabolism.
A synthetic ghrelin-receptor agonist studied for stimulation of growth-hormone secretion and endocrine signaling.
A selective ghrelin-receptor agonist researched for growth-hormone secretory effects with comparatively limited activity at some other endocrine receptors.
A short peptide derived from alpha-MSH studied in preclinical work for inflammatory signaling, epithelial biology, and immune modulation.
A naturally occurring compound involved in fatty-acid transport into mitochondria and widely studied in energy metabolism, exercise physiology, and metabolic health.
A synthetic peptide used primarily in cosmetic research for effects on neurotransmitter-associated signaling at the skin surface and the appearance of expression lines.
An investigational triple agonist targeting GIP, GLP-1, and glucagon receptors, under clinical study for obesity and metabolic disease.
A GLP-1 receptor agonist with established clinical uses and extensive research involving glucose regulation, appetite, cardiovascular outcomes, and obesity.
An investigational dual glucagon/GLP-1 receptor agonist studied in clinical trials for obesity and metabolic liver disease.
A dual GIP/GLP-1 receptor agonist with established clinical uses and extensive research in type 2 diabetes, obesity, and cardiometabolic outcomes.
Bacteriostatic water is a laboratory/pharmaceutical diluent containing a preservative. This catalog does not provide preparation or administration instructions.
A laboratory water/diluent reference entry. Exact formulation should be verified from manufacturer documentation before any laboratory use.
Another naming format for KPV, a short alpha-MSH-derived peptide investigated in preclinical inflammation and epithelial-barrier research.
This name is used in some research-product catalogs, but the exact chemical identity is not sufficiently clear from the name alone. Manufacturer documentation should be consulted before assigning a specific research description.
This name is used in some research-product catalogs, but the exact chemical identity is not sufficiently clear from the name alone. Manufacturer documentation should be consulted before assigning a specific research description.
A copper-binding peptide studied in cosmetic and tissue research, including extracellular-matrix signaling, skin conditioning, and hair-follicle biology.
An investigational combination of cagrilintide and semaglutide studied clinically for obesity and metabolic outcomes.
A long-acting amylin analog under clinical study for appetite regulation, body weight, and metabolic disease.
A GLP-1 receptor agonist with established clinical use and research involving glucose control and cardiovascular outcomes in type 2 diabetes.
A mixture generally referring to lipotropic nutrients with vitamin B12. Formulations vary, so the exact composition should be verified from manufacturer documentation.
An investigational dual GLP-1/glucagon receptor agonist studied for obesity and metabolic disease.
An adipotide-related research entry. Published adipotide research is largely preclinical; the exact meaning of the FTPP label should be verified from manufacturer documentation.
A trade-name family of cosmetic signal peptides used in skin research and formulations focused on extracellular-matrix proteins and visible signs of skin aging.
Nicotinamide adenine dinucleotide is a central redox cofactor studied broadly in energy metabolism, mitochondrial function, DNA repair, and cellular signaling.
A blend combining BPC-157 and a thymosin-beta-4-related product. Both are associated mainly with preclinical tissue-repair research; the blend itself has limited direct evidence.
A blend of BPC-157, GHK-Cu, TB-500, and KPV. Research on the individual components spans tissue repair, matrix biology, and inflammation; evidence for the combined blend is limited.
A blend of BPC-157, GHK-Cu, and TB-500. Research on the individual components focuses largely on tissue-repair and matrix biology; combination evidence is limited.
A synthetic peptide studied in neurobiology for neurotrophic signaling, cognition-related pathways, stress responses, and cerebral injury models. Evidence varies by indication and region.
A long-acting IGF-1 analog used in laboratory research on growth-factor signaling, cell growth, differentiation, and metabolism.
Delta sleep-inducing peptide is an experimental neuropeptide studied historically for sleep, stress, pain, and neuroendocrine signaling, with mixed and limited evidence.
A GHRH analog studied for stimulation of endogenous growth-hormone secretion and assessment of pituitary function.
A GHRH analog with an established clinical use and research involving growth-hormone/IGF-1 signaling and body-fat distribution.
A mitochondrial-derived peptide studied for metabolic signaling, cellular stress responses, exercise physiology, insulin sensitivity, and aging-related biology.
A supplier term commonly associated with thymosin-beta-4-related research. Thymosin beta-4 has been studied for cell migration, angiogenesis, wound repair, and tissue remodeling.
An experimental peptide studied mostly in animal and laboratory models for gastrointestinal protection, tendon/ligament biology, angiogenesis, and tissue repair. Human evidence is limited.
A small-molecule NNMT inhibitor used in preclinical research involving cellular metabolism, adipose biology, and energy expenditure. Human evidence is limited.
An AMP analog used in research to activate AMPK-related pathways and study energy sensing, glucose handling, fatty-acid oxidation, and exercise-like metabolic signaling.
An endogenous neuropeptide studied for wakefulness, arousal, appetite, reward, and autonomic regulation through orexin receptors.
An endogenous neuropeptide studied for wakefulness, arousal, appetite, reward, and autonomic regulation, with activity at both orexin receptors.
An experimental peptide described in preclinical neurobiology research involving neurotrophic pathways, synaptic plasticity, and cognitive models. Human evidence is not established.
A short peptide marketed/researched as a tissue-specific bioregulator associated with cardiac biology. Independent high-quality human evidence is limited.
A short peptide product associated with cartilage and connective-tissue research. Independent high-quality clinical evidence is limited.
A short peptide product associated with nervous-system and cortical tissue research. Independent high-quality clinical evidence is limited.
A short peptide product associated with immune/thymic bioregulator research. Independent high-quality clinical evidence is limited.
An experimental peptide construct investigated in preclinical studies involving Wnt/beta-catenin-associated signaling and tissue-regeneration biology.
A synthetic relaxin-family peptide agonist studied in preclinical models for fibrosis, cardiovascular signaling, and tissue remodeling.
A peptide product associated with respiratory-tissue bioregulator research. Independent high-quality human evidence is limited.
The exact identity associated with this name is not sufficiently clear from the name alone. Manufacturer documentation is needed before assigning a specific research description.
A shortened IGF-1 analog used in laboratory research on IGF receptor signaling, cell growth, differentiation, and local growth-factor effects.
A short peptide bioregulator studied in limited literature for neuronal stress, gene-expression, and cognition-related models. Evidence is preliminary.
An essential vitamin required for DNA synthesis, red-blood-cell formation, and neurologic function, widely studied in nutrition and deficiency research.
A common laboratory acid and solvent/reagent used in analytical chemistry and sample preparation. This catalog provides no preparation instructions.
A potent bacterial neurotoxin that blocks acetylcholine release. It has established medical and cosmetic uses and is also used to study neuromuscular transmission.
Vasoactive intestinal peptide is an endogenous neuropeptide studied for vasodilation, smooth-muscle signaling, circadian biology, immune regulation, and gastrointestinal physiology.
A thymic peptide studied for immune modulation, T-cell biology, innate immune responses, and infectious-disease and oncology research.
An experimental activin receptor type IIB fusion protein studied for inhibition of myostatin/activin signaling and effects on muscle mass. Development was limited by safety concerns.
Adrenocorticotropic hormone is a pituitary peptide studied for adrenal cortisol production, melanocortin receptor biology, and hypothalamic-pituitary-adrenal axis function.
A thymic peptide preparation associated with immune and aging research. Evidence quality and standardization vary across publications.
Also known as cibinetide in research, this peptide has been studied for tissue-protective, anti-inflammatory, and neuropathy-related signaling without strong erythropoietic activity.
A synthetic peptide studied primarily in Eastern European research for anxiety-related behavior, cognition, immune signaling, and neurotrophic pathways.
Oxytocin is an endogenous peptide hormone studied for uterine contraction, lactation, social behavior, stress, bonding, and broader neuroendocrine signaling.
A melanocortin receptor agonist with an established clinical use and research involving sexual-function pathways and central melanocortin signaling.
A melanocortin peptide related to alpha-MSH signaling and pigmentation biology. Afamelanotide is a regulated analog with an established clinical indication.
An experimental melanocortin receptor agonist studied for pigmentation, appetite, and sexual-function signaling. It is not an approved medication in the United States.
An endogenous hormone widely studied for circadian timing, sleep-wake regulation, antioxidant biology, and chronobiology.
A short peptide product associated with vascular/endothelial bioregulator research. Independent high-quality clinical evidence is limited.
A pegylated mechano-growth-factor-related research product used in experimental work on IGF-1 splice variants, muscle signaling, and tissue adaptation. Human evidence is limited.
An experimental peptide fragment investigated in preclinical work involving neuroplasticity and antidepressant-like behavioral pathways. Human evidence is limited.
An experimental p53-derived peptide studied in laboratory models for selective membrane-disrupting effects in certain cancer cells. It is not an established cancer treatment.
Myostatin is a growth factor that negatively regulates skeletal-muscle growth and is studied extensively in muscle development, wasting disorders, and signaling biology.
Erythropoietin is a glycoprotein hormone that regulates red-blood-cell production and is widely studied in hematology, hypoxia signaling, and tissue-protection biology.
An experimental peptide studied in preclinical senescence research for disruption of FOXO4-p53 interactions and selective effects on senescent cells.
A peptide-fragment reference entry. The exact parent peptide and intended research context are not sufficiently clear from the name alone and should be verified from manufacturer documentation.
A fragment of kisspeptin studied for activation of GnRH signaling and regulation of reproductive hormone pathways.
A synthetic GnRH peptide studied and used clinically for pituitary-gonadal axis testing and reproductive endocrine signaling.
A peptide mixture derived from porcine brain proteins and studied in some regions for stroke, traumatic brain injury, and cognitive disorders. Evidence and regulatory status vary by country.
A synthetic tetrapeptide associated with aging, circadian, and telomere-related research. Evidence is limited and not sufficient to establish broad clinical claims.
Educational reference only. No pricing, sales, dosing, reconstitution, preparation, administration, or treatment instructions are provided. Research the original literature and consult qualified professionals where appropriate.
Some entries may use shorthand, blend names, trade names, or research-only identifiers. Where an exact identity is unclear, the entry says so rather than guessing.